CancerNavigator, Inc

CancerNavigator, Inc, based in the US, offers specialized support services to guide cancer patients through their treatment journeys by connecting them with experienced medical professionals. Founded in 2020 and headquartered in Washington, US, CancerNavigator, Inc specializes in providing dedicated support to cancer patients. The company has conducted 1 deal to date, with its most recent deal occurring on February 18, 2026. No changes in business strategy or structure have been noted.

CancerNavigator provides a specialized support service aimed at guiding cancer patients through their treatment journeys by connecting them with well-equipped medical experts. The company employs Oncology Certified Nurses who offer 1:1 dedicated support, eliminating the need for apps or search tools. This personalized approach delivers custom education and guidance tailored to the specific types of cancer that patients are facing, ensuring they have the necessary information regarding in-network centers most suitable for their treatment. The primary client base includes employers and union health plans, with CancerNavigator serving over 50 such organizations across the United States.

CancerNavigator generates revenue through its partnerships with employer and union health plans, enabling these organizations to provide the CancerNavigator service to their members. The company operates on a B2B model, delivering its support services directly to employers and unions, who then offer the service as a benefit to their employees or members. The transaction structure is based on service agreements which outline the terms under which CancerNavigator provides its nursing support and educational services, aimed at improving patient access to specialized cancer care. In February 2026, CancerNavigator, Inc raised an undisclosed amount of venture funding from new investors Oncology Ventures and Texas Oncology.

The company plans to use this funding to build an operating system for oncology routing that proactively directs patients to appropriate cancer specialists using clinical, geographic, and provider-level data. This initiative reflects the company's strategy to enhance its offerings and improve patient navigation through their treatment journeys.